Marlowe (LON:MRL) Reaches New 12-Month High - Here's Why

Marlowe plc (LON:MRL - Get Free Report)'s stock price reached a new 52-week high during trading on Monday . The company traded as high as GBX 451 ($6.05) and last traded at GBX 438.92 ($5.89), with a volume of 5239475 shares. The stock had previously closed at GBX 441 ($5.92).

Analysts Set New Price Targets

Separately, Royal Bank Of Canada reissued a "sector perform" rating and issued a GBX 466 ($6.25) target price on shares of Marlowe in a report on Wednesday, July 16th.

Marlowe Stock Performance

The firm has a market capitalization of £351.23 million, a PE ratio of -40.82 and a beta of 0.44. The company has a debt-to-equity ratio of 58.99, a current ratio of 1.24 and a quick ratio of 0.80. The company's fifty day simple moving average is GBX 414.45 and its 200 day simple moving average is GBX 359.03.

Marlowe (LON:MRL - Get Free Report) last announced its quarterly earnings results on Thursday, June 26th. The company reported GBX 15.30 ($0.21) earnings per share (EPS) for the quarter. Marlowe had a negative net margin of 2.03% and a negative return on equity of 2.33%. As a group, equities research analysts expect that Marlowe plc will post 12.4863487 EPS for the current fiscal year.

About Marlowe

Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.